Compounds > risperidone
Page last updated: 2024-08-16

risperidone and ramelteon

risperidone has been researched along with ramelteon in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ishigooka, J; Naganawa, E; Nishimura, K; Otsubo, T; Tsuda, A1
Brodney, MA; Obach, RS; Walker, GS1
Hiwatani, Y; Nakane, S; Nakayama, Y; Takahashi, S; Tsuji, T; Uenishi, S; Ukai, S1

Reviews

1 review(s) available for risperidone and ramelteon

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for risperidone and ramelteon

ArticleYear
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Successfully treated delirium in an extremely elderly patient by switching from risperidone to ramelteon.
    Psychiatry and clinical neurosciences, 2013, Volume: 67, Issue:2

    Topics: Aged, 80 and over; Antipsychotic Agents; Delirium; Humans; Indenes; Male; Receptors, Melatonin; Risperidone

2013
Biosynthesis of Fluorinated Analogs of Drugs Using Human Cytochrome P450 Enzymes Followed by Deoxyfluorination and Quantitative Nuclear Magnetic Resonance Spectroscopy to Improve Metabolic Stability.
    Drug metabolism and disposition: the biological fate of chemicals, 2016, Volume: 44, Issue:5

    Topics: Aldehydes; Celecoxib; Cytochrome P-450 Enzyme System; Diethylamines; Fluorine; Halogenation; Humans; Hydroxylation; Indenes; Magnetic Resonance Spectroscopy; Microsomes, Liver; Midazolam; Pharmaceutical Preparations; Risperidone

2016
A case of autoimmune autonomic ganglionopathy with prolonged delirium.
    Asian journal of psychiatry, 2019, Volume: 39

    Topics: Adrenergic alpha-Antagonists; Aged; Antipsychotic Agents; Autoimmune Diseases; Autonomic Nervous System Diseases; Brain; Delirium; Diagnosis, Differential; Electroencephalography; Humans; Immunoglobulins; Indenes; Magnetic Resonance Imaging; Male; Mianserin; Risperidone; Time; Tomography, X-Ray Computed

2019